This inventor holds 2 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 3 EPO patents. Top assignees: The University of Tennessee Research Foundation, Other. Active years: 2007-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 789 
1 out of 834,601 Years Active: 2007-2011
Title: Gangadhar G Durgam: Innovator in LPA Receptor Research
Introduction
Gangadhar G Durgam is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that interact with LPA receptors. His work has implications for various medical treatments, showcasing his innovative approach to addressing complex health issues.
Latest Patents
Gangadhar G Durgam holds 2 patents related to LPA receptor agonists and antagonists. His latest patents disclose compounds according to a specific formula, along with pharmaceutical compositions that include these compounds. The methods of using such compounds are also detailed, highlighting their activity as agonists or antagonists of LPA receptors. These methods encompass a range of applications, including inhibiting LPA activity on an LPA receptor, modulating LPA receptor activity, treating cancer, enhancing cell proliferation, treating wounds, addressing apoptosis, and preserving or restoring function in cells, tissues, or organs. Additionally, the patents discuss the culturing of cells and treating dermatological conditions.
Career Highlights
Throughout his career, Gangadhar G Durgam has been associated with the University of Tennessee Research Foundation. His work there has allowed him to explore innovative solutions in the realm of pharmaceutical sciences. His research has contributed to the understanding and potential treatment of various medical conditions through the modulation of LPA receptor activity.
Collaborations
Gangadhar has collaborated with notable individuals in his field, including Duane Douglas Miller and Gabor G Tigyi. These collaborations have likely enriched his research and contributed to the advancement of knowledge in LPA receptor-related therapies.
Conclusion
Gangadhar G Durgam's innovative work in the field of LPA receptor research has led to significant advancements in pharmaceutical applications. His patents reflect a commitment to improving medical treatments and enhancing patient care. His contributions continue to influence the landscape of pharmaceutical sciences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile